Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00132769
Status:
COMPLETED
Last Update Posted:
2015-07-30
First Post:
2005-08-02
Brief Title:
A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients MK-0873-012COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Randomized Placebo-Controlled Parallel-Group Double-Blind 12-Week Study to Assess the Clinical Efficacy Safety and Tolerability of MK-0873 in Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will look at whether this new drug is effective in the treatment of rheumatoid arthritis and at whether it is safe and well-tolerated by participants with the disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_029 | OTHER | Telerex Study Number | None |